Characterization of Bacillus anthracis Persistence In Vivo by Jenkins, Sarah A. et al.
Characterization of Bacillus anthracis Persistence In Vivo
Sarah A. Jenkins, Yi Xu*
Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, United States of America
Abstract
Pulmonary exposure to Bacillus anthracis spores initiates inhalational anthrax, a life-threatening infection. It is known that
dormant spores can be recovered from the lungs of infected animals months after the initial spore exposure. Consequently,
a 60-day course antibiotic treatment is recommended for exposed individuals. However, there has been little information
regarding details or mechanisms of spore persistence in vivo. In this study, we investigated spore persistence in a mouse
model. The results indicated that weeks after intranasal inoculation with B. anthracis spores, substantial amounts of spores
could be recovered from the mouse lung. Moreover, spores of B. anthracis were significantly better at persisting in the lung
than spores of a non-pathogenic Bacillus subtilis strain. The majority of B. anthracis spores in the lung were tightly associated
with the lung tissue, as they could not be readily removed by lavage. Immunofluorescence staining of lung sections showed
that spores associated with the alveolar and airway epithelium. Confocal analysis indicated that some of the spores were
inside epithelial cells. This was further confirmed by differential immunofluorescence staining of lung cells harvested from
the infected lungs, suggesting that association with lung epithelial cells may provide an advantage to spore persistence in
the lung. There was no or very mild inflammation in the infected lungs. Furthermore, spores were present in the lung tissue
as single spores rather than in clusters. We also showed that the anthrax toxins did not play a role in persistence. Together,
the results suggest that B. anthracis spores have special properties that promote their persistence in the lung, and that there
may be multiple mechanisms contributing to spore persistence.
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Introduction
Anthrax infections are caused by the entry of Bacillus anthracis
spores into the host via the respiratory system, the gastrointestinal
tract, and cuts or wounds in the skin. Among these three forms,
inhalational anthrax has the highest lethality rate. One of the
characteristic features of inhalational anthrax is the prolonged
presence of spores in the lungs after an initial exposure. For
example, dormant spores of B. anthracis were recovered from the
lungs of non-human primates [1] and mice [2,3] weeks or months
post-exposure. It was also observed that sometimes there was a
delayed onset of anthrax infections (e.g., 58 days after exposure) in
exposed animals, and the persistence of spores in the lung was
thought to be responsible for the delay [4]. Based on these
observations, the current duration of antibiotic treatment recom-
mended for people with pulmonary exposure is 60 days.
Persistent colonization in a host by microbial pathogens has
been a challenge for effective treatment. A variety of mechanisms
contribute to pathogen persistence in the host. These mechanisms
include suppression of host innate immune responses [5],
modulation of complement activation [6], resistance to phagocytic
killing [7,8], adaptation to the intracellular environment or to the
mucosal surfaces [9,10], biofilm formation [11], and evasion of
host adaptive immunity [12]. For B. anthracis, the mechanism for
spore persistence in the lung has not been investigated but has
been largely attributed to the dormant nature and the resilience of
spores. However, recent findings raise the possibility that there
may be other factors contributing to spore persistence. Russell et al
showed that spores were found inside epithelial cells in the mouse
lung within hours after exposure to spores and that internalized
spores survived inside epithelial cells [13,14]. Thus the intracel-
lular environment of lung epithelial cells can potentially be a niche
for spores to persist. There has also been evidence for biofilm
formation by B. anthracis, B. subtilis and other related species and
the presence of spores within the biofilm [15,16,17].
In this study, we investigated spore persistence in mice over a
period of up to eight weeks. The spatial distribution of spores and
their association with different host cells were examined. We also
compared B. anthracis spores with spores from a non-pathogenic
Bacillus subtilis strain. The contribution of uptake by host cells and
anthrax toxins to spore persistence was also examined. The results
suggest that B. anthracis spores possess special properties that
promote their survival and persistence in the host.
Results
The lung is the primary site for B. anthracis spore
persistence
BALB/c mice were challenged intranasally (i.n.) with sub-lethal
doses of spores of B. anthracis Sterne strain 7702 (pXO1+, pXO22).
BALB/c mice are generally more resistant to the Sterne strain [18]
and therefore provided us a model to assay for persistence of
spores where mice can survive weeks post initial infection. The
presence of vegetative bacilli and spores in different organs was
evaluated over a period of 8 weeks. The results indicated that
substantial amounts of bacteria were recovered from the lungs of
mice at 2, 4 and 8 weeks post-inoculation (Fig. 1 and Table 1).
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The majority of the bacteria recovered were heat-resistant
dormant spores; however heat-sensitive vegetative bacilli were
also detected at all three time points. Immunofluorescence staining
of lung sections with antibodies specific for vegetative bacilli also
showed positive staining (Supplemental figure S1), indicating that
spore germination occurred in the lung although at a relatively low
frequency. We observed decreases in the total bacteria and spore
titers in the lung over the experimental period, suggesting a
continuous host clearance process. The decreases were signifi-
cantly sharper during the earlier weeks and were relatively
moderate from 4 to 8 weeks (Fig. 1 and Table 1).
To investigate if the lung was the major organ for spore
persistence we examined the bacterial burden in other tissues. The
bacterial titers in the spleen and kidney at 2 and 4 weeks were
significantly lower (approximately 103–104 fold) than those in the
lung (Fig. 2, A and B). Intranasal inoculation exposes the
nasopharynx associated lymphoid tissue (NALT) to the spores. A
previous report indicated that the NALT was among the first
organs in which vegetative growth was observed following
pulmonary exposure to spores [19]. We examined the bacterial
burden in the nasopharynx as well as the trachea at 2 and 4 weeks
post-inoculation. The results showed that both the total bacteria
and spore titers in the trachea and the nasopharynx were
significantly lower than those in the lung at both time points
(Fig. 2, A and B). These results indicate that the lung is the
primary site for spore persistence.
B. anthracis has special properties that contribute to its
ability to persist in mice
We next investigated whether the ability of B. anthracis spores to
persist in the lung was due to special properties of B. anthracis or
due to the dormant and resilient characteristics of spores in
general. Therefore, we examined if spores from Bacillus subtilis
could persist in the lung equally well as those from B. anthracis.
Mice were inoculated i.n. with approximately 1.36107 7702 or B.
subtilis strain PY79 spores. Lungs were harvested at 2 and 4 weeks
post-inoculation and evaluated for total viable bacteria and spores.
At both time points, significantly less bacteria or spores were
recovered from mice inoculated with B. subtilis compared to those
inoculated with B. anthracis (Fig. 3, A and B), suggesting that B.
anthracis spores are better at persisting in the mouse lung than B.
subtilis spores. Mice were also inoculated with overnight cultures of
E. coli HB101, a non-sporulating, non-pathogenic strain. These
mice had significantly fewer bacteria in the lung than those
infected with B. anthracis and B. subtilis, respectively (Fig. 3). We
also calculated the spore burden in the lung as a percentage of the
initial inoculum. At 2 weeks, the percentages were approximately
1.7%, 0.25% and 0.01% for mice infected with 7702, PY79 and E.
coli, respectively. At 4 weeks, the percentages were approximately
0.15%, 0.02% and 0.01% for the three strains, respectively. These
results suggest that in addition to dormancy and resilience, B.
anthracis spores may possess special properties, which are absent in
B. subtilis, that facilitate their persistence in the lung.
Association of spores with the lung epithelium, epithelial
cells, and phagocytes
We next examined whether the persistent B. anthracis spores
were tightly associated with the lung tissue or in the fluid lining the
respiratory epithelium, the latter of which can be recovered in the
bronchoaveolar lavage (BAL) fluid. The results showed that at
both 2 and 4 weeks post-inoculation, there were significantly more
total bacteria as well as spores in the lung tissues than in the BAL
fluid, suggesting that spores preferentially associated with lung
tissues (Fig. 4, A–D).
We further analyzed lung sections from infected mice to
determine the location of spores in the lung. Lung sections were
obtained from mice infected with B. anthracis spores at 2, 4, and 8
weeks. Hematoxylin and eosin (H&E) staining of the sections
showed minimal pathology in the lung (Fig. 5). The alveolar and
small airway epithelium as well as blood vessels appeared intact.
For most part of the lung, we observed no signs of inflammation
(Fig. 5, A, B, D, E, G and H). We occasionally observed isolated
foci that had inflammatory infiltrates at both 2 and 4 weeks (Fig.
5, C and F). At 8 weeks, the lungs were indistinguishable from the
uninfected lung (Fig. 5, G–L).
To detect spores in the lung, immunohistochemistry was
performed. Microscopic examination of the stained sections
revealed that spores were present in the lung at all three time
points. Spores were observed associated with the alveolar and the
small airway epithelium as single spores rather than in clusters
(Fig. 6, A–E), indicating that they did not form biofilms in the
lung. Additionally, spores were seen distributed relatively evenly
throughout the lung tissue similar to what was reported previously
[13,14]. Some of the spores that associated with the airway and
alveolar epithelium appeared intracellular. To determine if the
latter group of spores were indeed intracellular, we analyzed the Z-
stacks of confocal images of 124 potential intracellular spores from
2 and 4 weeks. Of these, 101 (81%) were surrounded by F-actin
(Fig. 7, A) or enclosed within the plasma membrane (Fig. 7, B)
and therefore were likely to be intracellular.
To investigate the specific cell types with which spores
associated, crude lung cell suspensions (CLCS) were prepared
from lungs harvested at 2 and 4 weeks post-inoculation. Epithelial
cells in the CLCS were detected using anti-cytokeratin antibodies
(Fig. 8, A). Approximately 23% of the CLCS cells were
cytokeratin-positive, consistent with previous results [13]. Approx-
imately 3.8% and 7.6% of epithelial cells examined were
associated with spores at 2 and 4 weeks, respectively. On average,
the percentage ratio of intracellular and extracellular adhered
spores relative to cytokeratin positive epithelial cells was
0.9560.4% and 2.7861.1% at 2 weeks, and 1.960.3% and
5.761.1% at 4 weeks, respectively (Fig. 8, B). Thus, spores
Figure 1. Bacterial and spore burden in the lungs of mice at 2,
4, and 8 weeks post-intranasal inoculation. Mice were inoculated
i.n. with ,1.16108 or ,1.36107 spores/mouse. Lungs were harvested
at 2, 4, and 8 weeks, homogenized, and dilution plated with or without
heat treatment. The results were combined from at least two
independent experiments. Closed circles represent total viable bacteria
and open circles heat-resistant dormant spores. *, p,0.05; **, p,0.01;
compared to respective total bacteria and spore titers at 2 weeks.
doi:10.1371/journal.pone.0066177.g001
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associated with lung epithelial cells both extracellularly and
intracellularly with the majority being extracellular. The CLCS
also contained lung dendritic cells and residual alveolar macro-
phages that were not removed by lavage. To determine spore
association with these phagocytes we stained the CLCS using anti-
CD11c antibodies. Multiple spores were often seen inside these
phagocytes (Fig. 8, C). Approximately 4.1% and 3.3% of CD11c+
cells contained spores at 2 and 4 weeks, respectively (Fig. 8, D).
We also stained the BAL fluids with anti-CD11b antibodies and
observed approximately 14.8% and 4.5% of CD11b+ cells
contained spores at 2 and 4 weeks, respectively (Fig. 8, E and
F). Many of the phagocytes appeared to be packed with spores
however, making accurate enumeration of the intracellular spores
difficult.
The anthrax toxins are not involved in spore persistence
in the lung
Minimal inflammation observed in the lung from the H&E
stained sections suggested that there was a subdued immune
response in the presence of spores. B. anthracis lethal factor (LF) is a
Zn2+-dependent metalloprotease that cleaves mitogen-activated
protein kinase kinases (MEKs) and plays an important role in
suppressing the host immune responses during anthrax infections
[20]. We observed a low level of spore germination in the lung
during the studies described above. LF was reported to be secreted
shortly after spores germinate [21]. We investigated the possibility
that LF secreted by the germinated spores suppressed the immune
response and contributed to spore persistence in the lung. We
compared the persistence of spores from the Sterne strain 7702
with that from the isogenic LF-deficient strain (Dlef) [22] as well as
a plasmid-free Sterne strain 9131, which does not produce any
anthrax toxins. We did not observe any significant difference in
either the total bacteria or the spore counts between the three
strains at 2 or 4 weeks post-inoculation (Fig. 9, A and B),
indicating that the anthrax toxins do not play a role in the
persistence of spores in the mouse lung.
Discussion
Recovery of B. anthracis spores from the lungs of animal hosts
weeks or months after the initial pulmonary exposure has been
known for decades and is the basis for the recommended 60-day
antibiotic regimen for people with pulmonary exposure to spores
[2,3,4]. However, beyond this knowledge detailed information on
how spores persist in vivo and factors contributing to persistence
was lacking. Here we investigated the spatial distribution of spores
in mice and the association of spores with different types of host
cells for up to 8 weeks. We also compared the persistence between
Table 1. Bacteria and spore burden in the lungs of mice.
Inoculum Average Retained Dosea Time Total Bacteria/Sporesb P valuec
(spores/mouse) (cfu±SEM) (weeks) (cfu6104/lung±SEM) (vs. 2 weeks)
2 3766.5/2065.0 -
1.36107 (1.560.1)6106 4 2.360.4/1.660.4 ,0.01/,0.05
8 1.360.6/1.160.6 ,0.01/,0.05
2 4169.7/3969.2 -
1.16108 (2.660.7)6107 4 9.262.3/4.461.3 ,0.01/,0.01
8 NDd NDd
aAverage retained dose was determined by harvesting the lungs 1 hour after intranasal inoculation and dilution plating the lung homogenates.
bThe amounts of total bacteria and spores in the lung as described in the Figure 1 legend are expressed as the mean6SEM at 2, 4, or 8 weeks post-inoculation. Results
are combined from two independent experiments.
cStatistical analysis was performed using the two-tailed Student’s t-test. *, p,0.05; **, p,0.01; compared to respective total bacteria and spore titers at 2 weeks.
dNot determined.
doi:10.1371/journal.pone.0066177.t001
Figure 2. Bacterial and spore burden in various organs at 2 and 4 weeks post-inoculation. Mice were inoculated i.n. with ,1.36107
spores/mouse. Bacterial burden in the lung, spleen, kidney, trachea, and nasopharynx (NP) at 2 (A) and 4 (B) weeks was determined as described in
the Materials and Methods section. The results were combined from at least 2 independent experiments. Closed circles represent total viable bacteria
and open circles heat-resistant dormant spores. **, p,0.01; ***, p,0.001; compared to respective total bacteria and spore titers in the lung.
doi:10.1371/journal.pone.0066177.g002
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B. anthracis spores and B. subtilis spores. The results provided
insights into the potential mechanisms underlying spore persis-
tence, as discussed below.
It has been reported that during late stages of acute inhalational
anthrax infections large amounts of vegetative bacilli of B. anthracis
were present in multiple organs including the liver, kidney,
lymphoid tissues, and even the brain, presumably via hematog-
enous spread [3,19]. Results from the current study suggest that
chronic persistence of spores in vivo exhibits a different pattern of
tissue distribution. The lung is the primary site for spore
persistence. We also recovered heat-sensitive bacilli in the lung,
but at significantly lower amounts compared to spore titers. These
results combined with positive staining of lung sections with
antibodies specific for vegetative bacilli suggest that there may be a
low level of spore germination in the lung during persistent
infections. It is possible that germination may occur inside host
cells as a number of previous studies suggested intracellular
germination using in vitro cultured cells [13,14,23,24]. The
possibility that spores germinate extracellularly in the lung at a
low frequency cannot be excluded either. It is possible that a
relatively large bolus of spores may cause damage to the lungs,
Figure 3. B. anthracis spores persisted in the lung significantly better than spores of B. subtilis. Mice were inoculated i.n. with 7702 spores
(B. ant), PY79 spores (B. sub), or overnight cultures of HB101 (E. coli) at a dose of ,1.36107 cfu/mouse. Lungs were harvested at 2 (A) and 4 (B) weeks
post-inoculation, homogenized, and plated for total viable bacteria (closed circles) or heat-resistant dormant spores (open circles). The results were
combined from at least 2 independent experiments. **, p,0.01; ***, p,0.001; compared to respective total bacteria and spore titers in B. anthracis
infected lungs.
doi:10.1371/journal.pone.0066177.g003
Figure 4. The majority of persisting spores associated tightly
with the lung tissue. Mice were inoculated i.n. with ,1.36107
spores/mouse (A and B) and ,1.16108 spores/mouse (C and D). Lungs
were lavaged with sterile PBS and collected. Total bacteria (closed
circles) and spore (open circles) titers in the lung tissues and BAL fluids
at 2 (A and C) and 4 (B and D) weeks were determined. The results
were combined from at least two independent experiments. *, p,0.05;
***, p,0.001; compared to respective total bacteria and spore titers in
the lung tissue.
doi:10.1371/journal.pone.0066177.g004
Figure 5. H&E stained lung sections of mice challenged with B.
anthracis spores. Lungs from infected and control mice were collected
at 2, 4, and 8 weeks post-inoculation, fixed and subjected to H&E
staining. Representative images displaying the alveoli and the airway
from mice infected for 2 (A–C), 4 (D–F), and 8 weeks (G–I), and
uninfected control mice (J–L) are shown. Scale bars represent 20 mm.
doi:10.1371/journal.pone.0066177.g005
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providing germinants not normally present due to spore abrasion
as suggested by Glomski et al [19]. In acute infections, the site of
spore germination after pulmonary exposure has been investigated
by different groups. Findings by Glomski et al [19] and Ross [25]
indicated that spore germination occurred in organs other than the
lung. However, studies by Sanz et al utilizing a Sterne strain that
specifically expressed bioluminescence only upon germination
reported germination proceeded in the lung [26]. The use of
different bacterial/mouse strains experimental methodologies
and/or different spore doses could have contributed to the
different conclusions [19]. We also observed some spores in the
other organs examined; however, the titers are orders of
magnitude lower than those in the lung. These spores presumably
spread to the distal organs via phagocytic cells.
The results also show that the majority of persistent B. anthracis
spores appeared to be tightly associated with lung tissues, as they
could not be readily removed by lavage. Further examination of
thin sections of the lung revealed that the spores adhered to the
alveolar and airway epithelium and some were inside the cells
lining the epithelium. This was further corroborated by immuno-
fluorescence staining of lung cells harvested from the infected
lungs. Differential immunofluorescence staining of lung epithelial
cells indicated that there were more extracellularly adhered spores
than intracellular ones. This suggests that adherence to the lung
epithelium may be an important mechanism for spores to persist in
the lung. Residing in an intracellular niche of lung epithelial cells
may be a secondary mechanism. The results also indicated that
epithelial cells were not the only cell type that spores associated
with. We observed spores inside CD11b+ and CD11c+ cells at both
2 and 4 weeks, and most of the spores appeared intact. The results
in Fig. 4 indicated that viable spores were recovered from the
BAL fluids at 2 and 4 weeks. These results suggest that spores may
be viable inside the phagocytes, consistent with previous reports
that spores were able to survive inside phagocytic cells [27].
Therefore, it is possible that the intracellular environment of
phagocytic cells is a niche for spore persistence. On the other
hand, the fate of phagocytosed B. anthracis spores has been
investigated by multiple groups with somewhat controversial
results. Spores are thought to germinate inside macrophages.
Some of the studies reported replication of vegetative bacilli inside
macrophages [21,24,28], while others showed killing of germinat-
ed spores and vegetative bacilli by macrophages [29,30,31].
Therefore, recovery of viable spores from phagocytes does not
exclude the possibility of phagocytic killing of germinated spores
and vegetative bacilli. Also, it is possible that the amount of spores
has an impact on the fate of B. anthracis within macrophages
[30,32]. The finding that total bacteria and spore titers in the lung
significantly decreased over the experimental period, while the
titers in other organs examined remained very low suggested a
continuous host clearance process. Therefore, it is also possible
that the spore-bearing CD11b+ and CD11C+ cells we observed
reflect a part of the clearance process.
We investigated if the ability to persist in the lung could be a
general phenomenon of Bacillus spores, i.e., if spores from other
species of Bacillus could also persist in the lung. The significantly
lower bacterial/spore burden in the lungs of mice exposed to
spores of a B. subtilis strain suggests that B. anthracis spores possess
special properties that promote their survival and persistence in
the lung. B. subtilis spores are known to share a similar coat protein
profile as that of B. anthracis spores but lack an exosporium which is
Figure 6. Representative images of immunofluorescently stained lung sections from mice challenged with B. anthracis spores. Mice
were infected i.n. with ,108 spores/mouse. Lungs were harvested at 2 and 4 weeks, fixed, sectioned and stained with anti-BclA antibodies and
secondary antibodies conjugated to Alexa Fluor 594 (red), Alexa Fluor 488-conjugated phalliodin (green) and DAPI (blue), as described in the
Materials and Methods section. Representative images are shown to indicate spore association with the small airway epithelium (A and B) and the
alveolar epithelium (C–E). Arrows indicate spores. The areas around those spores were enlarged and shown in boxed insets. Scale bars represent
10 mm.
doi:10.1371/journal.pone.0066177.g006
Figure 7. Confocal analysis of immunofluorescently stained
lung sections. Lung sections were stained as described in the
Materials and Methods section and analyzed by confocal microscopy.
Representative images are shown. A, an image showing a spore (red)
surrounded by F-actin (green). The projections show all planar views,
including xy (center panel), xz (right panel) and yz (top panel)-stacks. B,
the section was stained with wheat germ agglutinin to outline the
plasma membrane (red) and anti-BclA antibodies to detect spores
(green). Scale bars represent 10 mm.
doi:10.1371/journal.pone.0066177.g007
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present on the latter [33]. The exosporium is the outermost
integument of B. anthracis spores and is composed of 20–30
proteins and glycoproteins [34,35,36]. It is possible that specific
exosporium components contribute to B. anthracis spore persistence
in the lung. It was previously shown that surface components on B.
anthracis spores were sufficient to mediate spore adherence and
entry into epithelial cells [14] and that B. subtilis spores were much
poorer at adherence or entry into host cells [37]. It was reported
previously that entry of B. anthracis spores into epithelial cells was
mediated by the spore surface glycoprotein BclA and host cell
receptor integrin a2b1 via a novel mechanism that requires
complement component C1q as a bridging molecule [38]. Spores
from a BclA deletion mutant (DbclA) showed decreased entry into
epithelial cells compared to spores from the isogenic parent strain
[38]. However, other studies reported a different role for BclA that
it reduces spore entry into non-phagocytic host cells [39,40]. One
of the factors contributing to the discrepancy may be the
germination status of spores in the assays. It seems that if spores
remain dormant, BclA plays an important role in host cell entry
via the BclA-C1q-a2b1 pathway. However, if spores are allowed
to germinate in the assay media, having BclA appeared to be a
disadvantage in host cell entry [38]. As the majority of spores
remain dormant in the host lung, results from dormant spores are
likely to be more relevant to the in vivo situation. Studies to
investigate the role of BclA in spore persistence in vivo is currently
underway in our laboratory.
Evans et al. reported that a bacterial lysate could induce innate
resistance to infections caused by pulmonary exposure to B.
anthracis spores. The authors further demonstrated that lung
epithelial cells rather than macrophages or neutrophils were
responsible for the induced resistance [41]. This demonstrates that
the lung epithelium is an important player in the host defense
against infections by B. anthracis spores. It is conceivable that in
addition to mediating adherence and entry, interactions between
exosporium components and the lung epithelium may also
influence the host immune responses in a way that favors the
survival of spores in the lung. We are currently carrying out studies
to investigate the precise role of specific exosporium components
in spore persistence.
The very mild inflammation and pathology observed in the lung
is also indicative of a subdued immune reaction to B. anthracis
spores. While the spore surface does not have any typical
pathogen-associated molecular patterns such as LPS, LTA,
peptidoglycan, or flagellin, a number of studies indicated that B.
anthracis spores are not ‘‘stealth’’ to host immune recognition.
Spores are capable of activating Toll-like receptor 2 and MyD88-
dependent signaling [42], inducing inflammatory cytokine pro-
duction in both MyD88-dependent and independent manners
[43,44], activating natural killer cells [45,46] and initiating the
classical complement pathway via a direct interaction between the
exosporium component BclA and C1q [47]. These findings from
the literature suggest that the subdued immune response may be
due to an active immune evasion/suppression mechanism of B.
Figure 8. Spore association with epithelial cells and phago-
cytes in the lung. Mice were inoculated i.n. with ,1.16108 spores per
mouse. At 2 and 4 weeks post-infection, lungs were harvested and
digested to obtain CLCS. Lungs were also lavaged to obtain BAL fluid.
A, a representative image of a lung epithelial cell stained with anti-
cytokeratin antibodies (blue) containing an extracellular spore (red,
long arrow) and an intracellular one (green, short arrow). B, the
percentage ratio of intracellular and extracellular adhered spores
relative to the number of cytokeratin+ cells counted at 2 and 4 weeks
post-inoculation, expressed as the mean6standard error of the mean
(SEM). Approximately 500–600 cytokeratin+ cells were counted per
mouse. C and E, representative images of cells stained positive with
CD11c antibodies (C, red) and CD11b antibodies (E, red). Spores were
stained green. Blue indicates DAPI staining for the nuclei. D and F, the
percentage ratio of spore-containing CD11c+ and CD11b+ cells relative
to the total number of CD11c+ and CD11b+ cells counted at 2 and 4
weeks post-inoculation, respectively, expressed as the mean6SEM.
Approximately 100 CD11c+ cells and 500–600 CD11b+ cells were
counted per mouse. Scale bars represent 10 mm. **, p,0.01 comparison
between 2 to 4 weeks % spore-bearing CD11b+ cells.
doi:10.1371/journal.pone.0066177.g008
Figure 9. Bacterial and spore burden in the lungs of mice
infected with toxin-deficient B. anthracis mutants. Mice were
inoculated i.n. with ,1.56107 spores. Lungs were harvested at 2 and 4
weeks post inoculation, homogenized and plated with or without heat
treatment. The results were combined from two independent
experiments. Closed circles represent total viable bacteria and open
circles heat-resistant dormant spores.
doi:10.1371/journal.pone.0066177.g009
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anthracis rather than passive inactivity of the spores. We
demonstrated that the anthrax toxins, in particular the lethal
factor, a major immune suppressor of B. anthracis, did not play a
role in spore persistence in the lung. This implies that B. anthracis
exosporium components may have immune suppression proper-
ties. We are currently investigating this possibility.
In summary, the results described in this study suggest that there
are likely multiple mechanisms contributing to spore persistence in
the mouse lung. Association with the lung epithelium and immune
suppression/evasion are two potential mechanisms. The results
also suggest that spore surface components play important roles in
mediating persistence. The work presented here has provided a
foundation for further studies to elucidate the molecular mecha-
nisms responsible for spore persistence. Understanding the
mechanisms of persistence may potentially provide clues for
developing more effective therapeutic regimens for anthrax
infections and have implications for other persistent or chronic
infections in general.
Materials and Methods
Bacterial strains and spore preparation
B. anthracis Sterne strain 7702, its isogenic toxin-deficient mutant
strain (Dlef) [22], plasmid-free B. anthracis strain 9131 derived from
Sterne Strain 7702, and B. subtilis strain PY79 were provided by T.
M. Koehler, Univ. of Texas, Houston, TX. Spores of these strains
were prepared by culturing in PA media for 10 days at 30uC as
described previously [13]. E. coli HB101 was grown in Luria Broth
overnight at 37uC with shaking. The overnight cultures were
washed three times with sterile PBS prior to inoculation into mice.
Bacterial counts were determined by plating on Luria Broth agar
plates and incubation overnight at 37uC.
Mouse infections
All animal experiments were carried out according to proce-
dures approved by the Institutional Animal Care and Use
Committee, Texas A&M Health Science Center, Institute of
Biosciences and Technology (IBT). BALB/c mice were originally
purchased from the Jackson Laboratory and maintained in the
IBT animal facility. For infection experiments, 6–8 weeks old and
sex-matched mice were used. Mice were inoculated with spores or
E. coli by intranasal instillation (i.n.) as previously described [48].
Briefly, mice were anesthetized with avertin (0.3 mg/g) by
intraperitoneal injection (i.p.). Mice were then inoculated i.n. with
20 mls of a sub-lethal dose of spores (LD50 was determined in pilot
studies to be ,1.76108 spores/mouse). Mice were monitored
twice daily. Mice mostly appeared healthy with no physical signs of
distress or illness throughout the experiments. To determine the
bacterial burden in various organs mice were euthanized by i.p.
injection of avertin followed by exsanguination via the inferior
cava vein. Lungs, kidneys, spleen, trachea and nasopharynx were
collected at indicated time points. The tissues were homogenized
in sterile cold PBS plus D-alanine, pH 7.4 (1 ml final volume)
using a tissue homogenizer (Fisher Scientific). BAL fluids were
collected by lavaging the lungs with sterile PBS twice. The
homogenates and BAL fluids were either directly diluted and
plated to determine the number of total viable bacteria or heated
at 68uC for 1 hr and dilution plated to determine the number of
heat-resistant spores.
Isolation and immunofluorescence staining of crude lung
cell suspension (CLCS)
Lungs were harvested from mice at indicated time points and
digested as previously described to obtain crude lung cells [13].
The CLCS was stained using a previously described procedure
[13] with some modifications. To stain for specific cell types and
spores, cells in the CLCS were allowed to attach to poly-L-lysine
coated coverslips and then blocked with PBS containing 5% goat
serum. Anti-BclA antibodies (rabbit polyclonal antibodies raised
against recombinant BclA, a spore surface protein, 1:100) was
added to the cells and incubated for 2 hours followed by secondary
antibodies conjugated to Alexa Fluor 594 to detect extracellular
spores. Cells were then permeabilized, blocked and incubated
again with anti-BclA antibodies followed by secondary antibodies
conjugated to Alexa Fluor 488 to detect both extracellular and
intracellular spores. Epithelial cells were detected with a pan
epithelial mouse monoclonal antibody (Clone C-11, Chemicon,
1:250) recognizing different isoforms (4, 5, 6, 8, 10, 13, and 18) of
cytokeratin, an epithelial specific marker, followed by secondary
antibodies conjugated to Alexa Fluor 350. Anti-CD11c and anti-
CD11b antibodies (Caltag Laboratories, 1:250) were used to stain
phagocytes in the CLCS and BAL fluids, respectively. Coverslips
were mounted on slides using Fluorsave (Calbiochem) and viewed
with a Zeiss Axiovert 135 microscope with the Axio Vision
Software.
Histology and immunofluorescence staining of lung
sections
This was done following a previously described procedure with
slight modifications [13]. Briefly, lungs were harvested at indicated
time points and fixed in 10% formalin. Embedding, sectioning and
H&E staining were performed at the Breast Center Pathology
Laboratory, Baylor College of Medicine, Houston, TX. To detect
spores, lung sections were incubated in a solution containing anti-
BclA antibodies (1:250) for 2.5 hours followed by incubation with
Alexa Fluor 594-conjugated secondary antibodies for 1 hr.
Phalloidin Alexa Fluor 488 was used to stain F-actin. DAPI was
used to stain the nuclei. Some lung sections were also stained with
wheat germ agglutinin Texas Red 595 (Invitrogen, 1:1000) to
detect the plasma membrane. All dilutions were made in PBS
pH 7.4 containing 2.5% fetal bovine serum. Five slides per mouse
at each time point were examined. Lung sections were viewed with
a Zeiss Axiovert 135 fluorescence microscope with the Axio Vision
Software and an LSM 510 confocal laser scanning fluorescent
microscope with the LSM 4.0 software (Zeiss).
Statistical analysis
Statistical analysis was performed using the two-tailed Student’s
t-test (Graph-Pad Prism 4.0).
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Supporting Information
Figure S1 Detection of vegetative bacilli in the lung by
immunofluorescence staining. A, Antibodies against BclA
and CW7 are specific for spores and vegetative bacilli, respective-
ly. Spores of B. anthracis Sterne strain 7702 were incubated in
DMEM, 10% FBS for 0hr (spores) and 3hrs (vegetative bacilli).
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Bacteria were then spun onto poly-L-lysine coated coverslips and
subjected to immunofluorescence staining. Antibodies against
BclA and CW7, a cell wall anchored protein of B. anthracis, were
rabbit antibodies raised against purified recombinant proteins of
BclA and CW7. Secondary antibodies were goat anti-rabbit IgG–
Alexa Fluor 633. Spores were pre-labeled with FITC for
visualization. Fluorescence from FITC was barely visible after
3hrs of incubation; therefore, vegetative bacilli were visualized by
staining their nuclei with DAPI. B, Detection of vegetative bacilli
using anti-CW7 antibodies. A representative image of positive
CW7 staining of a lung section from a mouse lung harvested at 2
weeks post-inoculation. Lung sections were fixed, sectioned, and
stained with rabbit anti-CW7 antibodies and secondary antibodies
conjugated to Alexa Fluor 594 (red), Alexa Fluor 488-conjugated
phalliodin (green) and DAPI (blue). Scale bar represents 10 mm.
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